Maria Teresa Bertilaccio, PhD
Department of Leukemia, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Associate Professor, Leukemia - Research, The University of Texas MD Anderson Cancer Center, Houston, Texas
Assistant Professor, Leukemia - Research, The University of Texas MD Anderson Cancer Center, Houston, TX
Regular Member of the Graduate School Faculty, UT Health Graduate School of Biomedical Sciences, Houston, TX
Education & Training
Degree-Granting Education
| 2008 | San Raffaele Vita-Salute University, Milan, IT, Molecular Medicine-Immunology/Active immunotherapy strategies for Prostate Cancer, Ph.D |
| 2001 | University of Pisa, Pisa, IT, Biological Sciences/Cytogenetics, M.S |
Postgraduate Training
| 2016-2018 | Sr. Research Scientist, Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2016-2016 | Senior Scientist, Experimental Oncology, San Raffaele Scientific Institute, Milan |
| 2011-2015 | Project Leader, Molecular Oncology/Lymphoid Malignancies, San Raffaele Scientific Institute, Milan |
| 2006-2010 | Postdoctoral Fellow, Molecular Oncology/Lymphoid Malignancies, San Raffaele Scientific Institute, Milan |
| 2005-2006 | Visiting Scientist, Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington |
| 2004-2004 | Visiting Scientist, Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington |
| 2002-2003 | Research Collaborator, Angiogenesis and Space Research, Sciences and Molecular Technologies Institute, Milan |
| 2001-2002 | Research Collaborator, Molecular Oncology, San Raffaele Scientific Institute, Milan |
Experience & Service
Administrative Appointments/Responsibilities
Co-leader, CLL Moon Shot Program, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Other Professional Positions
Member of the Faculty Senate, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - 2023
Member of the Review Panel, 14th Annual Faculty recognition & Award Program, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019
Member of the Seminar Committee, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2024
Responsible of the in vivo platform for transgenic and xenograft models of B lymphoid malignancies, in the 5-year AIRC 5x1000 Research Program, San Raffaele Scientific Institute, Milan, 2010 - 2014
Honors & Awards
| 2010 - 2011 | Fellowship from Ferrero S.p.A, Ferrero S.p.A |
| 2007 - 2009 | Fellowship from Italian Foundation for Cancer Research, Italian Foundation for Cancer Research |
| 2002 - 2003 | Fellowship from National Research Council, Italian Space Agency |
Grant & Contract Support
| Date: | 2024 - 2025 |
| Title: | Characterize and molecularly profile the immune system of patients with RT to identify future targetable immune-based biomarkers |
| Funding Source: | UTMDACC Moon Shots Program, CGL Platform collaboration |
| Role: | PI |
| Date: | 2024 - 2025 |
| Title: | Immune microenvironment in CLL and Richter transformation |
| Funding Source: | UTMDACC Moon Shots Program, TMP-IL Platform collaboration |
| Role: | PI |
| Date: | 2023 - 2028 |
| Title: | Curing chronic lymphocytic leukemia with immunotherapy |
| Funding Source: | Rosemary and Daniel J. Harrison III |
| Role: | Co-PI |
| Date: | 2023 - 2025 |
| Title: | Immune mapping and restoration in chronic lymphocytic leukemia |
| Funding Source: | CLL GLOBAL RESEARCH FOUNDATION |
| Role: | PI |
| Date: | 2022 - 2023 |
| Title: | Immune-based treatments |
| Funding Source: | UTMDACC Moon Shot |
| Role: | PI |
| Date: | 2021 - 2022 |
| Title: | Targeting Immunosuppression in CLL |
| Funding Source: | UTMDACC Moon Shots Program |
| Role: | Principal Investigator-MDACC |
| Date: | 2020 - 2021 |
| Title: | Targeting immunosuppression |
| Funding Source: | UTMDACC Moon Shots Program |
| Role: | PI |
| Date: | 2020 - 2023 |
| Title: | Immune Mapping in chronic lymphocytic leukemia |
| Funding Source: | CLL Global Research Foundation |
| Role: | PI |
| Date: | 2019 - 2020 |
| Title: | Deciphering the immunosuppressive cell network and repairing immune dysfunction in CLL |
| Funding Source: | UTMDACC Moon Shots Program |
| Role: | Co-I |
Selected Publications
Peer-Reviewed Articles
- Rodriguez-Sevilla JJ, Ganan-Gomez I, Kumar B, Thongon N, Ma F, Chien KS, Kim YJ, Yang H, Loghavi S, Tan R, Adema V, Li Z, Tanaka T, Uryu H, Kanagal-Shamanna R, Al-Atrash G, Bejar R, Banerjee PP, Lynn Cha S, Montalban-Bravo G, Dougherty M, Fernandez Laurita MC, Wheeler N, Jia B, Papapetrou EP, Izzo F, Duenas DE, McAllen S, Gu Y, Todisco G, Ficara F, Della Porta MG, Jain A, Takahashi K, Clise-Dwyer K, Halene S, Bertilaccio MTS, Garcia-Manero G, Daher M, Colla S. Natural killer cells' functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromes. Nat Commun 16(1):3450, 2025. e-Pub 2025. PMID: 40216768.
- Veletic I, Harris DM, Rozovski U, Bertilaccio MTS, Calin GA, Takahashi K, Li P, Liu Z, Manshouri T, Drula RC, Furudate K, Muftuoglu M, Hossain A, Wierda WG, Keating MJ, Estrov Z. CLL cell-derived exosomes alter the immune and hematopoietic systems. Leukemia 39(6):1380-1394, 2025. e-Pub 2025. PMID: 40186065.
- Zhang R, Khare P, Banerjee P, Ivan C, Schneider S, Barbaglio F, Clise-Dwyer K, Jensen VB, Thompson E, Mendoza M, Chiorazzi N, Chen SS, Yan XJ, Jain N, Ghia P, Caligaris-Cappio F, Mendonsa R, Kasimsetty S, Swoboda R, Bayraktar R, Wierda W, Gandhi V, Calin GA, Keating MJ, Bertilaccio MTS. The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemia. Blood Cancer J 14(1):168, 2024. e-Pub 2024. PMID: 39438453.
- Dragomir, M, Fuentes-Mattei, E, Winkle, M, Okubo, K, Bayraktar, R, Knutsen, E, Qdaisat, AZ, Chen, M, Li, Y, Shimizu, M, Pang, L, Liu, K, Liu, X, Anfossi, S, Zhang, H, Koch, I, Tran, AM, Mohapatra, S, Ton, AN, Kaplan, M, Anderson, MW, Rothfuss, SJ, Silasi, R, Keshari, RS, Ferracin, M, Ivan, C, Rodriguez-Aguayo, C, Lopez Berestein, G, Georgescu, C, Banerjee, PP, Basar, R, Li, Z, Horst, D, Vasilescu, C, Bertilaccio, MS, Rezvani, K, Lupu, F, Yeung, SJ, Calin, GA. Anti–miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response. Journal of Clinical Investigation 133(14), 2023. e-Pub 2023. PMID: 37261908.
- Tettamanti S, Rotiroti MC, Giordano Attianese GMP, Arcangeli S, Zhang R, Banerjee P, Galletti G, McManus S, Mazza M, Nicolini F, Martinelli G, Ivan C, Veliz Rodriguez T, Barbaglio F, Scarfò L, Ponzoni M, Wierda W, Gandhi V, Keating M, Biondi A, Caligaris-Cappio F, Biagi E, Ghia P, Bertilaccio MTS. Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia. Leuk Lymphoma 63(7):1-14, 2022. e-Pub 2022. PMID: 35259043.
- Aslan B, Kismali G, Iles LR, Manyam GC, Ayres ML, Chen LS, Gagea M, Bertilaccio MTS, Wierda WG, Gandhi V. Pirtobrutinib inhibits wild-type and mutant Bruton's tyrosine kinase-mediated signaling in chronic lymphocytic leukemia. Blood Cancer J 12(5):80, 2022. e-Pub 2022. PMID: 35595730.
- Severin F, Urbani A, Varanita T, Bachmann M, Azzolini M, Martini V, Pizzi M, Tos APD, Frezzato F, Mattarei A, Ghia P, Bertilaccio MTS, Gulbins E, Paradisi C, Zoratti M, Semenzato GC, Leanza L, Trentin L, Szabò I. Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model. J Exp Clin Cancer Res 41(1):64, 2022. e-Pub 2022. PMID: 35172855.
- Aslan B, Kismali G, Chen LS, Iles LR, Mahendra M, Peoples M, Gagea M, Fowlkes NW, Zheng X, Wang J, Vellano CP, Marszalek JR, Bertilaccio MTS, Gandhi V. Development and characterization of prototypes for in vitro and in vivo mouse models of ibrutinib-resistant CLL. Blood Adv 5(16):3134-3146, 2021. e-Pub 2021. PMID: 34424317.
- Grioni M, Brevi A, Cattaneo E, Rovida A, Bordini J, Bertilaccio MTS, Ponzoni M, Casorati G, Dellabona P, Ghia P, Bellone M, Calcinotto A. CD4+ T cells sustain aggressive chronic lymphocytic leukemia in Eμ-TCL1 mice through a CD40L-independent mechanism. Blood Adv 5(14):2817-2828, 2021. e-Pub 2021. PMID: 34269799.
- Yi X, Sarkar A, Kismali G, Aslan B, Ayres M, Iles LR, Keating MJ, Wierda WG, Long JP, Bertilaccio MTS, Gandhi V. AMG-176, an Mcl-1 antagonist, shows preclinical efficacy in chronic lymphocytic leukemia. Clin Cancer Res 26(14):3856-3867, 2020. e-Pub 2020. PMID: 31937611.
- Banerjee P, Zhang R, Ivan C, Galletti G, Clise-Dwyer K, Barbaglio F, Scarfò L, Aracil M, Klein C, Wierda W, Plunkett W, Caligaris-Cappio F, Gandhi V, Keating MJ, Bertilaccio MTS. Trabectedin reveals a strategy of immunomodulation in chronic lymphocytic leukemia. Cancer Immunol Res 7(12):2036-2051, 2019. e-Pub 2019. PMID: 31530560.
- Riva F, Ponzoni M, Supino D, Bertilaccio MTS, Polentarutti N, Massara M, Pasqualini F, Carriero R, Innocenzi A, Anselmo A, Veliz-Rodriguez T, Simonetti G, Anders HJ, Caligaris-Cappio F, Mantovani A, Muzio M, Garlanda C. IL1R8 Deficiency Drives Autoimmunity-Associated Lymphoma Development. Cancer Immunol Res 7(6):874-885, 2019. e-Pub 2019. PMID: 31018956.
- Van Roosbroeck K, Bayraktar R, Calin S, Bloehdorn J, Dragomir MP, Okubo K, Bertilaccio MTS, Zupo S, You MJ, Gaidano G, Rossi D, Chen SS, Chiorazzi N, Thompson PA, Ferrajoli A, Bertoni F, Stilgenbauer S, Keating MJ, Calin GA. miRNAs involvement in the pathogenesis of Richter's syndrome. Haematologica 104(5):1004-1015, 2019. e-Pub 2019. PMID: 30409799.
- Farinello D, Wozinska M, Lenti E, Genovese L, Bianchessi S, Migliori E, Sacchetti N, di Lillo A, Bertilaccio MTS, de Lalla C, Valsecchi R, Gleave SB, Lligé D, Scielzo C, Mauri L, Ciampa MG, Scarfò L, Bernardi R, Lazarevic D, Gonzalez-Farre B, Bongiovanni L, Campo E, Cerutti A, Ponzoni M, Pattini L, Caligaris-Cappio F, Ghia P, Brendolan A. A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression. Nat Commun 9(1):1787, 2018. e-Pub 2018. PMID: 29725010.
- Gorini F, Azzimonti L, Delfanti G, Scarfo L, Scielzo C, Bertilaccio MT, Ranghetti P, Gulino A, Doglioni C, Di Napoli A, Capri M, Franceschi C, Caligaris-Cappio F, Ghia P, Bellone M, Dellabona P, Casorati G, de Lalla C. Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis. Blood 129(26):3440-3451, 2017. e-Pub 2017. PMID: 28465341.
- Bordini J, Galvan S, Ponzoni M, Bertilaccio MT, Chesi M, Bergsagel PL, Camaschella C, Campanella A. Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma. Leukemia 31(4):967-970, 2017. e-Pub 2017. PMID: 27881873.
- Bianco M, Gasparri A, Generoso L, Assi E, Colombo B, Scarfò L, Bertilaccio MT, Scielzo C, Ranghetti P, Dondossola E, Ponzoni M, Caligaris-Cappio F, Ghia P, Corti A. Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models. Oncotarget 7(27):41725-41736, 2016. e-Pub 2016. PMID: 27203389.
- Bianco M, Gasparri AM, Colombo B, Curnis F, Girlanda S, Ponzoni M, Bertilaccio MT, Calcinotto A, Sacchi A, Ferrero E, Ferrarini M, Chesi M, Bergsagel PL, Bellone M, Tonon G, Ciceri F, Marcatti M, Caligaris-Cappio F, Corti A. Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients. Cancer Res 76(7):1781-91, 2016. e-Pub 2016. PMID: 26869462.
- Valsecchi R, Coltella N, Belloni D, Ponente M, Ten Hacken E, Scielzo C, Scarfò L, Bertilaccio MT, Brambilla P, Lenti E, Martinelli Boneschi F, Brendolan A, Ferrero E, Ferrarini M, Ghia P, Tonon G, Ponzoni M, Caligaris-Cappio F, Bernardi R. HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment. Blood 127(16):1987-97, 2016. e-Pub 2016. PMID: 26825709.
- Galletti G, Scielzo C, Barbaglio F, Rodriguez TV, Riba M, Lazarevic D, Cittaro D, Simonetti G, Ranghetti P, Scarfò L, Ponzoni M, Rocchi M, Corti A, Anselmo A, van Rooijen N, Klein C, Ries CH, Ghia P, De Palma M, Caligaris-Cappio F, Bertilaccio MTS. Targeting Macrophages Sensitizes Chronic Lymphocytic Leukemia to Apoptosis and Inhibits Disease Progression. Cell Rep 14(7):1748-1760, 2016. e-Pub 2016. PMID: 26876171.
- Agathangelidis A, Scarfò L, Barbaglio F, Apollonio B, Bertilaccio MT, Ranghetti P, Ponzoni M, Leone G, De Pascali V, Pecciarini L, Ghia P, Caligaris-Cappio F, Scielzo C. Establishment and Characterization of PCL12, a Novel CD5+ Chronic Lymphocytic Leukaemia Cell Line. PLoS One 10(7), 2015. e-Pub 2015. PMID: 26110819.
- Calcinotto A, Ponzoni M, Ria R, Grioni M, Cattaneo E, Villa I, Sabrina Bertilaccio MT, Chesi M, Rubinacci A, Tonon G, Bergsagel PL, Vacca A, Bellone M. Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma. Oncoimmunology 4(6):e1008850, 2015. e-Pub 2015. PMID: 26155424.
- Bordini J, Bertilaccio MT, Ponzoni M, Chesi M, Bergsagel PL, Camaschella C, Campanella A. Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myeloma. Haematologica 100(6):834-841, 2015. e-Pub 2015. PMID: 25715406.
- Apollonio B, Bertilaccio MT, Restuccia U, Ranghetti P, Barbaglio F, Ghia P, Caligaris-Cappio F, Scielzo C. From a 2DE-gel spot to protein function: lesson learned from HS1 in chronic lymphocytic leukemia. J Vis Exp(92):e51942, 2014. e-Pub 2014. PMID: 25350848.
- Simonetti G, Bertilaccio MT, Rodriguez TV, Apollonio B, Dagklis A, Rocchi M, Innocenzi A, Casola S, Winkler TH, Nitschke L, Ponzoni M, Caligaris-Cappio F, Ghia P. SIGLEC-G deficiency increases susceptibility to develop B-cell lymphoproliferative disorders. Haematologica 99(8):1356-64, 2014. e-Pub 2014. PMID: 24859880.
- Simonetti G, Bertilaccio MT, Ghia P, Klein U. Mouse models in the study of chronic lymphocytic leukemia pathogenesis and therapy. Blood 124(7):1010-9, 2014. e-Pub 2014. PMID: 25006127.
- Cottini F, Hideshima T, Xu C, Sattler M, Dori M, Agnelli L, ten Hacken E, Bertilaccio MT, Antonini E, Neri A, Ponzoni M, Marcatti M, Richardson PG, Carrasco R, Kimmelman AC, Wong KK, Caligaris-Cappio F, Blandino G, Kuehl WM, Anderson KC, Tonon G. Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers. Nat Med 20(6):599-606, 2014. e-Pub 2014. PMID: 24813251.
- Martins LR, Lúcio P, Melão A, Antunes I, Cardoso BA, Stansfield R, Bertilaccio MT, Ghia P, Drygin D, Silva MG, Barata JT. Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia. Leukemia 28(1):179-82, 2014. e-Pub 2014. PMID: 23925046.
- Bertino P, Panigada M, Soprana E, Bianchi V, Bertilaccio S, Sanvito F, Rose AH, Yang H, Gaudino G, Hoffmann PR, Siccardi A, Carbone M. Fowlpox-based survivin vaccination for malignant mesothelioma therapy. Int J Cancer 133(3):612-23, 2013. e-Pub 2013. PMID: 23335100.
- Apollonio B, Scielzo C, Bertilaccio MT, Ten Hacken E, Scarfò L, Ranghetti P, Stevenson F, Packham G, Ghia P, Muzio M, Caligaris-Cappio F. Targeting B-cell anergy in chronic lymphocytic leukemia. Blood 121(19):3879-88, S1-8, 2013. e-Pub 2013. PMID: 23460614.
- Acquati F, Lualdi M, Bertilaccio S, Monti L, Turconi G, Fabbri M, Grimaldi A, Anselmo A, Inforzato A, Collotta A, Cimetti L, Riva C, Gribaldo L, Ghia P, Taramelli R. Loss of function of Ribonuclease T2, an ancient and phylogenetically conserved RNase, plays a crucial role in ovarian tumorigenesis. Proc Natl Acad Sci U S A 110(20):8140-5, 2013. e-Pub 2013. PMID: 23630276.
- ten Hacken E, Scielzo C, Bertilaccio MT, Scarfò L, Apollonio B, Barbaglio F, Stamatopoulos K, Ponzoni M, Ghia P, Caligaris-Cappio F. Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia. Blood 121(12):2264-73, 2013. e-Pub 2013. PMID: 23325840.
- Bertilaccio MT, Simonetti G, Dagklis A, Rocchi M, Rodriguez TV, Apollonio B, Mantovani A, Ponzoni M, Ghia P, Garlanda C, Caligaris-Cappio F, Muzio M. Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models. Blood 118(3):660-9, 2011. e-Pub 2011. PMID: 21652674.
- Giordano Attianese GM, Marin V, Hoyos V, Savoldo B, Pizzitola I, Tettamanti S, Agostoni V, Parma M, Ponzoni M, Bertilaccio MT, Ghia P, Biondi A, Dotti G, Biagi E. In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor. Blood 117(18):4736-45, 2011. e-Pub 2011. PMID: 21406718.
- Acquati F, Bertilaccio S, Grimaldi A, Monti L, Cinquetti R, Bonetti P, Lualdi M, Vidalino L, Fabbri M, Sacco MG, van Rooijen N, Campomenosi P, Vigetti D, Passi A, Riva C, Capella C, Sanvito F, Doglioni C, Gribaldo L, Macchi P, Sica A, Noonan DM, Ghia P, Taramelli R. Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase. Proc Natl Acad Sci U S A 108(3):1104-9, 2011. e-Pub 2011. PMID: 21189302.
- Scielzo C, Bertilaccio MT, Simonetti G, Dagklis A, ten Hacken E, Fazi C, Muzio M, Caiolfa V, Kitamura D, Restuccia U, Bachi A, Rocchi M, Ponzoni M, Ghia P, Caligaris-Cappio F. HS1 has a central role in the trafficking and homing of leukemic B cells. Blood 116(18):3537-46, 2010. e-Pub 2010. PMID: 20530793.
- Scielzo C, Ten Hacken E, Bertilaccio MT, Muzio M, Calissano C, Ghia P, Caligaris-Cappio F. How the microenvironment shapes chronic lymphocytic leukemia: the cytoskeleton connection. Leuk Lymphoma 51(8):1371-4, 2010. e-Pub 2010. PMID: 20687794.
- Bertilaccio MT, Scielzo C, Simonetti G, Ponzoni M, Apollonio B, Fazi C, Scarfò L, Rocchi M, Muzio M, Caligaris-Cappio F, Ghia P. A novel Rag2-/-gammac-/--xenograft model of human CLL. Blood 115(8):1605-9, 2010. e-Pub 2010. PMID: 20018917.
- Fazi C, Dagklis A, Cottini F, Scarfò L, Bertilaccio MT, Finazzi R, Memoli M, Ghia P. Monoclonal B cell lymphocytosis in hepatitis C virus infected individuals. Cytometry B Clin Cytom 78 Suppl 1:S61-8, 2010. e-Pub 2010. PMID: 20839339.
- Maugeri N, Rovere-Querini P, Evangelista V, Covino C, Capobianco A, Bertilaccio MT, Piccoli A, Totani L, Cianflone D, Maseri A, Manfredi AA. Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and {beta}2 integrin-dependent cell clearance program. Blood 113(21):5254-65, 2009. e-Pub 2009. PMID: 19264679.
- Muzio M, Scielzo C, Bertilaccio MT, Frenquelli M, Ghia P, Caligaris-Cappio F. Expression and function of toll like receptors in chronic lymphocytic leukaemia cells. Br J Haematol 144(4):507-16, 2009. e-Pub 2009. PMID: 19036098.
- Bertilaccio MT, Grioni M, Sutherland BW, Degl'Innocenti E, Freschi M, Jachetti E, Greenberg NM, Corti A, Bellone M. Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer. Prostate 68(10):1105-15, 2008. e-Pub 2008. PMID: 18437689.
- Degl'Innocenti E, Grioni M, Capuano G, Jachetti E, Freschi M, Bertilaccio MT, Hess-Michelini R, Doglioni C, Bellone M. Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells. Cancer Res 68(1):292-300, 2008. e-Pub 2008. PMID: 18172322.
- Iezzi G, Boni A, Degl'Innocenti E, Grioni M, Bertilaccio MT, Bellone M. Type 2 cytotoxic T lymphocytes modulate the activity of dendritic cells toward type 2 immune responses. J Immunol 177(4):2131-7, 2006. e-Pub 2006. PMID: 16887972.
- Casati A, Zimmermann VS, Benigni F, Bertilaccio MT, Bellone M, Mondino A. The immunogenicity of dendritic cell-based vaccines is not hampered by doxorubicin and melphalan administration. J Immunol 174(6):3317-25, 2005. e-Pub 2005. PMID: 15749863.
- Degl'Innocenti E, Grioni M, Boni A, Camporeale A, Bertilaccio MT, Freschi M, Monno A, Arcelloni C, Greenberg NM, Bellone M. Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunization. Eur J Immunol 35(1):66-75, 2005. e-Pub 2005. PMID: 15597325.
- Carlsson SI, Bertilaccio MT, Ballabio E, Maier JA. Endothelial stress by gravitational unloading: effects on cell growth and cytoskeletal organization. Biochim Biophys Acta 1642(3):173-9, 2003. e-Pub 2003. PMID: 14572900.
- Carlsson SI, Bertilaccio MT, Ascari I, Bradamante S, Maier JA. Modulation of human endothelial cell behaviour in simulated microgravity. J Gravit Physiol 9(1):273-4, 2002. e-Pub 2002. PMID: 15002577.
Review Articles
- McManus S, Khare P, Bertilaccio MTS. Neutrophils unveiled in chronic lymphocytic leukemia. Front Immunol 16:1609754, 2025. e-Pub 2025. PMID: 40909277.
- Bertilaccio MTS, Chen SS. Mouse models of chronic lymphocytic leukemia and Richter transformation: what we have learnt and what we are missing. Front Immunol 15:1376660, 2024. e-Pub 2024. PMID: 38903501.
- Bayraktar R, Bertilaccio MTS, Calin GA. The Interaction Between Two Worlds: MicroRNAs and Toll-Like Receptors. Front Immunol 10:1053, 2019. e-Pub 2019. PMID: 31139186.
- Galletti G, Caligaris-Cappio F, Bertilaccio MT. B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia. Leukemia 30(12):2293-2301, 2016. e-Pub 2016. PMID: 27677742.
- Caligaris-Cappio F, Bertilaccio MT, Scielzo C. How the microenvironment wires the natural history of chronic lymphocytic leukemia. Semin Cancer Biol 24:43-8, 2014. e-Pub 2014. PMID: 23831274.
- Bertilaccio MT, Scielzo C, Simonetti G, Ten Hacken E, Apollonio B, Ghia P, Caligaris-Cappio F. Xenograft models of chronic lymphocytic leukemia: problems, pitfalls and future directions. Leukemia 27(3):534-40, 2013. e-Pub 2013. PMID: 23041721.
- Bertilaccio MT, Scielzo C, Muzio M, Caligaris-Cappio F. An overview of chronic lymphocytic leukaemia biology. Best Pract Res Clin Haematol 23(1):21-32, 2010. e-Pub 2010. PMID: 20620968.
- Muzio M, Bertilaccio MT, Simonetti G, Frenquelli M, Caligaris-Cappio F. The role of toll-like receptors in chronic B-cell malignancies. Leuk Lymphoma 50(10):1573-80, 2009. e-Pub 2009. PMID: 19672768.
Other Articles
- Cottini, F, Hideshima, T, Xu, C, Sattler, M, Dori, M, Agnelli, L, Ten Hacken, E, Bertilaccio, MS, Antonini, E, Neri, A, Ponzoni, M, Marcatti, M, Richardson, PG, Carrasco, R, Kimmelman, AC, Wong, KK, Caligaris-Cappio, F, Blandino, G, Kuehl, WM, Anderson, KC, Tonon, G Editorial Expression of Concern. Nature medicine 32(3):1161, 2026. PMID: 41741727.
- Agathangelidis A, Scarfo L, Barbaglio F, Apollonio B, Bertilaccio MT, Ranghetti P, Ponzoni M, Leone G, De Pascali V, Pecciarini L, Ghia P, Caligaris-Cappio F, Scielzo C Correction: Establishment and Characterization of PCL12, a Novel CD5+ Chronic Lymphocytic Leukaemia Cell Line. PLoS One 10(7):e0134748, 2015. PMID: 26222697.
Book Chapters
- Bertilaccio MTS, Zhang R, Banerjee P, Gandhi V. In Vitro Assay to Study CLL and Monocyte Interactions. In: Methods Mol Biol. Methods Mol Biol, 113-119, 2019.
Patient Reviews
CV information above last modified September 03, 2026